A detailed history of Lindbrook Capital, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 826 shares of TGTX stock, worth $24,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
826
Previous 754 9.55%
Holding current value
$24,400
Previous $13,000 46.15%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$17.21 - $25.28 $1,239 - $1,820
72 Added 9.55%
826 $19,000
Q2 2024

Jul 31, 2024

BUY
$13.32 - $19.19 $559 - $805
42 Added 5.9%
754 $13,000
Q1 2024

Apr 25, 2024

SELL
$13.02 - $21.3 $911 - $1,491
-70 Reduced 8.95%
712 $10,000
Q4 2023

Jan 31, 2024

BUY
$6.68 - $18.81 $2,625 - $7,392
393 Added 101.03%
782 $13,000
Q3 2023

Oct 25, 2023

BUY
$8.36 - $26.5 $367 - $1,166
44 Added 12.75%
389 $3,000
Q2 2023

Jul 28, 2023

BUY
$15.48 - $35.0 $232 - $525
15 Added 4.55%
345 $8,000
Q1 2023

Apr 26, 2023

BUY
$10.23 - $19.34 $276 - $522
27 Added 8.91%
330 $4,000
Q4 2022

Jan 24, 2023

BUY
$5.01 - $11.83 $1,017 - $2,401
203 Added 203.0%
303 $0
Q3 2022

Nov 10, 2022

SELL
$4.57 - $8.4 $1,096 - $2,016
-240 Reduced 70.59%
100 $1,000
Q2 2022

Aug 01, 2022

SELL
$3.74 - $10.66 $213 - $607
-57 Reduced 14.36%
340 $1,000
Q1 2022

Apr 21, 2022

SELL
$7.81 - $20.45 $5,631 - $14,744
-721 Reduced 64.49%
397 $4,000
Q4 2021

Jan 18, 2022

SELL
$15.2 - $35.51 $21,006 - $49,074
-1,382 Reduced 55.28%
1,118 $21,000
Q3 2021

Nov 05, 2021

SELL
$21.78 - $40.45 $10,890 - $20,225
-500 Reduced 16.67%
2,500 $83,000
Q2 2021

Jul 27, 2021

BUY
$32.5 - $48.96 $13,000 - $19,584
400 Added 15.38%
3,000 $116,000
Q1 2021

Apr 28, 2021

BUY
$41.61 - $54.3 $45,771 - $59,730
1,100 Added 73.33%
2,600 $125,000
Q4 2020

Jan 27, 2021

BUY
$25.27 - $54.9 $12,635 - $27,450
500 Added 50.0%
1,500 $78,000
Q2 2020

Jul 27, 2020

BUY
$8.9 - $21.84 $8,900 - $21,840
1,000 New
1,000 $19,000
Q2 2019

Jul 24, 2019

SELL
$6.27 - $8.65 $6,270 - $8,650
-1,000 Closed
0 $0
Q4 2018

Feb 07, 2019

BUY
$3.44 - $5.76 $3,440 - $5,760
1,000 New
1,000 $4,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.